(1S,2S,5R)-3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 95.0%, 250mg

2-Isopropoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 100mg

3,5-Dibromo-2-methylpyridin-4-amine, 95+%, 500mg

TERT-BUTYL 2-BROMOPHENETHYLCARBAMATE, 95.0%, 5g

N-(2-(1H-indol-3-yl)ethyl)naphthalene-2-sulfonamide, 90%, 1g

Balance d'analyse et de précision Série Entris® II Modèles à réglage externe, non certifiés, 0,01 g, 820 g, BCE822-1S

2,6-Dichloroquinoxaline, 95.0%, 10g

N-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 95.0%, 25g

2-Bromo-6-fluorobenzoic acid, 98.0%, 100g

BRIVANIB ALANINATE, 95%, 25mg

4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol, 95.0%, 5g

Ethyl 4-(trifluoromethyl)benzoate, 97.0%, 25g

Lenalidomide-PEG1-azide, 25mg